Details of the Drug

General Information of Drug (ID: DM2L6TX)

Drug Name

ADS051

Indication

Disease Entry	ICD 11	Status	REF
Ulcerative colitis	DD71	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05084261) A Multicenter, Randomized, Placebo-Controlled, Multiple-Ascending-Dose Investigation of the Oral Anti-Inflammatory Agent BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC). U.S.National Institutes of Health.